EDOC vs. FTXH
EDOC (Global X Telemedicine & Digital Health ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both Health & Biotech Equities funds - EDOC tracks the Solactive Telemedicine & Digital Health Index- TR Net while FTXH tracks the Nasdaq U.S. Smart Pharmaceuticals Index. Both are passively managed. Over the past 5 years, EDOC returned -14.16%/yr vs 8.33%/yr for FTXH. At a 0.49 correlation, their price movements are largely independent. EDOC charges 0.68%/yr vs 0.60%/yr for FTXH.
Performance
EDOC vs. FTXH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EDOC achieves a -12.84% return, which is significantly lower than FTXH's 7.62% return.
EDOC
- 1D
- 3.24%
- 1M
- 1.39%
- YTD
- -12.84%
- 6M
- -18.63%
- 1Y
- -19.59%
- 3Y*
- -9.61%
- 5Y*
- -14.16%
- 10Y*
- —
FTXH
- 1D
- 2.50%
- 1M
- 3.66%
- YTD
- 7.62%
- 6M
- 9.20%
- 1Y
- 39.54%
- 3Y*
- 12.33%
- 5Y*
- 8.33%
- 10Y*
- —
EDOC vs. FTXH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
EDOC Global X Telemedicine & Digital Health ETF | -12.84% | -0.62% | -2.87% | -12.61% | -29.99% | -14.21% | 23.87% |
FTXH First Trust Nasdaq Pharmaceuticals ETF | 7.62% | 24.15% | 2.98% | -1.41% | 2.55% | 6.14% | 8.02% |
Correlation
The correlation between EDOC and FTXH is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.42 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.45 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.49 |
Correlation (All Time) Calculated using the full available price history since Jul 31, 2020 | 0.49 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EDOC vs. FTXH — Risk / Return Rank
EDOC
FTXH
EDOC vs. FTXH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Telemedicine & Digital Health ETF (EDOC) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EDOC | FTXH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.21 | ||
| Sortino ratioReturn per unit of downside risk | -4.60 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.39 | -0.52 |
| Calmar ratioReturn relative to maximum drawdown | -0.64 | 5.32 | -5.96 |
| Martin ratioReturn relative to average drawdown | -1.29 | 15.35 | -16.64 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EDOC | FTXH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.89 | 2.32 | -3.21 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.54 | 0.51 | -1.05 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.38 | 0.39 | -0.77 |
Drawdowns
EDOC vs. FTXH - Drawdown Comparison
The maximum EDOC drawdown since its inception was -65.76%, which is greater than FTXH's maximum drawdown of -32.11%. Use the drawdown chart below to compare losses from any high point for EDOC and FTXH.
Loading charts...
Drawdown Indicators
| EDOC | FTXH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.76% | -32.11% | -33.65% |
Max Drawdown (1Y)Largest decline over 1 year | -30.71% | -7.47% | -23.24% |
Max Drawdown (3Y)Largest decline over 3 years | -35.78% | -19.51% | -16.27% |
Max Drawdown (5Y)Largest decline over 5 years | -60.36% | -19.51% | -40.85% |
Current DrawdownCurrent decline from peak | -62.37% | -0.45% | -61.92% |
Average DrawdownAverage peak-to-trough decline | -43.04% | -5.84% | -37.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.21% | 2.58% | +12.63% |
Volatility
EDOC vs. FTXH - Volatility Comparison
Global X Telemedicine & Digital Health ETF (EDOC) has a higher volatility of 6.11% compared to First Trust Nasdaq Pharmaceuticals ETF (FTXH) at 5.38%. This indicates that EDOC's price experiences larger fluctuations and is considered to be riskier than FTXH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EDOC | FTXH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.11% | 5.38% | +0.73% |
Volatility (6M)Calculated over the trailing 6-month period | 16.03% | 11.96% | +4.07% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.13% | 17.14% | +4.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.41% | 16.34% | +10.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.21% | 18.43% | +7.78% |
EDOC vs. FTXH - Expense Ratio Comparison
EDOC has a 0.68% expense ratio, which is higher than FTXH's 0.60% expense ratio.
Dividends
EDOC vs. FTXH - Dividend Comparison
EDOC's dividend yield for the trailing twelve months is around 0.38%, less than FTXH's 1.19% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
EDOC Global X Telemedicine & Digital Health ETF | 0.38% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% |
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.19% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% |
Frequently Asked Questions
EDOC and FTXH have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EDOC has higher volatility (6.11%) compared to FTXH (5.38%). In terms of maximum drawdown, EDOC dropped -65.76% vs FTXH's -32.11%.
On 5-year performance, FTXH leads with 8.33% vs -14.16% for EDOC. On fees, FTXH is cheaper at 0.60% per year. On volatility, FTXH has been the lower-risk option at 5.38%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FTXH has performed better with a 8.33% return vs -14.16%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FTXH is cheaper with a 0.60% expense ratio, compared with 0.68% for EDOC.
FTXH has the higher dividend yield at 1.19%, compared with 0.38% for EDOC.
EDOC tracks Solactive Telemedicine & Digital Health Index- TR Net, while FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index. They also come from different issuers: Global X and First Trust. Their fees differ too: 0.68% for EDOC and 0.60% for FTXH.
FTXH currently has the higher Sharpe Ratio (2.32 vs -0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EDOC and FTXH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer